135 related articles for article (PubMed ID: 18640043)
1. Muscarinic receptor 1 agonist activity of novel N-arylthioureas substituted 3-morpholino arecoline derivatives in Alzheimer's presenile dementia models.
Malviya M; Kumar YC; Asha D; Chandra JN; Subhash MN; Rangappa KS
Bioorg Med Chem; 2008 Aug; 16(15):7095-101. PubMed ID: 18640043
[TBL] [Abstract][Full Text] [Related]
2. Muscarinic receptor 1 agonist activity of novel N-aryl carboxamide substituted 3-morpholino arecoline derivatives in Alzheimer's presenile dementia models.
Malviya M; Kumar YC; Mythri RB; Venkateshappa C; Subhash MN; Rangappa KS
Bioorg Med Chem; 2009 Aug; 17(15):5526-34. PubMed ID: 19595599
[TBL] [Abstract][Full Text] [Related]
3. Effect of novel N-aryl sulfonamide substituted 3-morpholino arecoline derivatives as muscarinic receptor 1 agonists in Alzheimer's dementia models.
Kumar YC; Malviya M; Chandra JN; Sadashiva CT; Kumar CS; Prasad SB; Prasanna DS; Subhash MN; Rangappa KS
Bioorg Med Chem; 2008 May; 16(9):5157-63. PubMed ID: 18359231
[TBL] [Abstract][Full Text] [Related]
4. Effect of novel arecoline thiazolidinones as muscarinic receptor 1 agonist in Alzheimer's dementia models.
Chandra JN; Malviya M; Sadashiva CT; Subhash MN; Rangappa KS
Neurochem Int; 2008 Feb; 52(3):376-83. PubMed ID: 17719699
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and pharmacological evaluation of novel N-alkyl/aryl substituted thiazolidinone arecoline analogues as muscarinic receptor 1 agonist in Alzheimer's dementia models.
Sadashiva CT; Chandra JN; Kavitha CV; Thimmegowda A; Subhash MN; Rangappa KS
Eur J Med Chem; 2009 Dec; 44(12):4848-54. PubMed ID: 19717214
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological characterization of 1,4,5,6-tetrahydropyrimidine and 2-amino-3,4,5,6-tetrahydropyridine derivatives as selective m1 agonists.
Messer WS; Abuh YF; Liu Y; Periyasamy S; Ngur DO; Edgar MA; El-Assadi AA; Sbeih S; Dunbar PG; Roknich S; Rho T; Fang Z; Ojo B; Zhang H; Huzl JJ; Nagy PI
J Med Chem; 1997 Apr; 40(8):1230-46. PubMed ID: 9111297
[TBL] [Abstract][Full Text] [Related]
7. Bioisosteres of arecoline: 1,2,3,6-tetrahydro-5-pyridyl-substituted and 3-piperidyl-substituted derivatives of tetrazoles and 1,2,3-triazoles. Synthesis and muscarinic activity.
Moltzen EK; Pedersen H; Bøgesø KP; Meier E; Frederiksen K; Sánchez C; Løve Lembøl H
J Med Chem; 1994 Nov; 37(24):4085-99. PubMed ID: 7990109
[TBL] [Abstract][Full Text] [Related]
8. Quantitative structure-selectivity relationship for M2 selectivity between M1 and M2 of piperidinyl piperidine derivatives as muscarinic antagonists.
Niu YY; Yang LM; Deng KM; Yao JH; Zhu L; Chen CY; Zhang M; Zhou JE; Shen TX; Chen HZ; Lu Y
Bioorg Med Chem Lett; 2007 Apr; 17(8):2260-6. PubMed ID: 17289384
[TBL] [Abstract][Full Text] [Related]
9. 1,2,5-Thiadiazole derivatives of arecoline stimulate M1 receptors coupled to phosphoinositide turnover.
Periyasamy S; Messer WS; Roknich S; Sauerberg P; Hoss W
Brain Res; 1995 Sep; 693(1-2):118-23. PubMed ID: 8653399
[TBL] [Abstract][Full Text] [Related]
10. Cognitive effects of muscarinic M1 functional agonists in non-human primates and clinical trials.
McArthur RA; Gray J; Schreiber R
Curr Opin Investig Drugs; 2010 Jul; 11(7):740-60. PubMed ID: 20571970
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of curcuminoids on acetylcholinesterase activity and attenuation of scopolamine-induced amnesia may explain medicinal use of turmeric in Alzheimer's disease.
Ahmed T; Gilani AH
Pharmacol Biochem Behav; 2009 Feb; 91(4):554-9. PubMed ID: 18930076
[TBL] [Abstract][Full Text] [Related]
12. Active site directed docking studies: synthesis and pharmacological evaluation of cis-2,6-dimethyl piperidine sulfonamides as inhibitors of acetylcholinesterase.
Girisha HR; Narendra Sharath Chandra JN; Boppana S; Malviya M; Sadashiva CT; Rangappa KS
Eur J Med Chem; 2009 Oct; 44(10):4057-62. PubMed ID: 19493592
[TBL] [Abstract][Full Text] [Related]
13. Discovery of N-substituted 7-azaindoline derivatives as potent, orally available M1 and M4 muscarinic acetylcholine receptors selective agonists.
Takai K; Inoue Y; Konishi Y; Suwa A; Uruno Y; Matsuda H; Nakako T; Sakai M; Nishikawa H; Hashimoto G; Enomoto T; Kitamura A; Uematsu Y; Kiyoshi A; Sumiyoshi T
Bioorg Med Chem Lett; 2014 Jul; 24(14):3189-93. PubMed ID: 24856064
[TBL] [Abstract][Full Text] [Related]
14. Discovery of N-{1-[3-(3-oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.
Sams AG; Hentzer M; Mikkelsen GK; Larsen K; Bundgaard C; Plath N; Christoffersen CT; Bang-Andersen B
J Med Chem; 2010 Sep; 53(17):6386-97. PubMed ID: 20684563
[TBL] [Abstract][Full Text] [Related]
15. The profile of sabcomeline (SB-202026), a functionally selective M1 receptor partial agonist, in the marmoset.
Harries MH; Samson NA; Cilia J; Hunter AJ
Br J Pharmacol; 1998 May; 124(2):409-15. PubMed ID: 9641560
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of isoxazoline derivatives as potent M₁ muscarinic acetylcholine receptor agonists.
Huang M; Suk DH; Cho NC; Bhattarai D; Kang SB; Kim Y; Pae AN; Rhim H; Keum G
Bioorg Med Chem Lett; 2015 Apr; 25(7):1546-51. PubMed ID: 25765911
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease.
Pomara N; Sidtis JJ
N Engl J Med; 2010 May; 362(19):1844; author reply 1844-5. PubMed ID: 20463348
[No Abstract] [Full Text] [Related]
18. [Synthesis and vascular relaxing activity of arecoline derivatives coupled with nitric oxide donors].
Huang ST; Huang WL; Zhang HB
Yao Xue Xue Bao; 2006 Jan; 41(1):71-5. PubMed ID: 16683531
[TBL] [Abstract][Full Text] [Related]
19. Enhanced arecoline derivatives as muscarinic acetylcholine receptor M1 ligands for potential application as PET radiotracers.
Ozenil M; Pacher K; Balber T; Vraka C; Roller A; Holzer W; Spreitzer H; Mitterhauser M; Wadsak W; Hacker M; Pichler V
Eur J Med Chem; 2020 Oct; 204():112623. PubMed ID: 32717485
[TBL] [Abstract][Full Text] [Related]
20. Ex vivo study of 5-HT(1A) and 5-HT(7) receptor agonists and antagonists on cAMP accumulation during memory formation and amnesia.
Perez-García G; Meneses A
Behav Brain Res; 2008 Dec; 195(1):139-46. PubMed ID: 18723050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
